Monday, August 31, 2015 11:09:44 AM
I agree completely. A major reason for a PI would have been the concept of irreparable market damage. That is now past history. To whatever extent they could regain pricing power, the additional delay would not likely matter much.
But what about a settlement? The driving force behind this would be the same as "pay for delay". The situation is not even close to zero sum between the players.
Is it reasonably safe to assume that Teva is or is not infringing to the same extent as Amphastar? If so, given the earlier action by the trial Judge, the defendants would have to assume a decent chance of losing.
We are certainly talking billions at risk, and some companies would be very happy to walk away paying chump change and let Sandoz get the future profits (at least for the patent duration).
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM